Predictive Oncology Share Price (NASDAQ: POAI)

$0.87

▲

-0.04

(-4.4%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Predictive Oncology Stock chart to analyse performance

Predictive Oncology stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$0.87
Today's High:$0.90
$0.87
0.0%
Downside
Day's Volatility :3.44%
Upside
3.44%
52 Weeks Low:$0.55
52 Weeks High:$3.06
$0.87
36.78%
Downside
52 Weeks Volatility :82.03%
Upside
71.57%

Predictive Oncology Stock Returns

Period	Predictive Oncology Inc	Index (Russel 2000)
3 Months	-8.14%	0.0%
6 Months	-30.74%	0.0%
1 Year	-8.71%	0.0%
3 Years	-89.18%	-4.7%

Predictive Oncology Inc Key Stats

Check Predictive Oncology key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.91
Open	$0.901
Today's High	$0.901
Today's Low	$0.87
Market Capitalization	$10.0M
Today's Volume	$36.3K
52 Week High	$3.06
52 Week Low	$0.55
Revenue TTM	$1.7M
EBITDA	$-9.7M
Earnings Per Share (EPS)	$-1.13
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-746.03%

Stock Returns calculator for Predictive Oncology Stock including INR - Dollar returns

The Predictive Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Predictive Oncology investment value today

Current value as on today

₹95,909

Returns

₹4,091

(-4.09%)

Returns from Predictive Oncology Stock

₹9,375 (-9.37%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Predictive Oncology Stock

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Predictive Oncology Stock from India on INDmoney has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Predictive Oncology Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
0.70%
Geode Capital Management, LLC
0.62%
UBS Group AG
0.19%
State Street Corp
0.14%
Carnegie Mellon University
0.10%
Tower Research Capital LLC
0.01%

Analyst Recommendation on Predictive Oncology Stock

Rating

Trend

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Predictive Oncology(by analysts ranked 0 to 5 stars)

Predictive Oncology Share Price Target

What analysts predicted

Upside of 244.83%

Target:

$3.00

Current:

$0.87

Predictive Oncology share price target is $3.00, a slight Upside of 244.83% compared to current price of $0.87 as per analysts' prediction.

Predictive Oncology Stock Insights

Price Movement
In the last 3 years, POAI stock has moved down by -89.4%
Decreasing Revenue
Revenue is down for the last 3 quarters, 611.58K → 2.68K (in $), with an average decrease of 89.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -2.44M → -2.07M (in $), with an average increase of 18.0% per quarter
POAI vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 84.7% return, outperforming this stock by 93.4%
POAI vs DOCS (3 yr)
In the last 3 years, Doximity, Inc. has given 108.5% return, outperforming this stock by 197.9%
Price to Sales
ForPOAI every $1 of sales, investors are willing to pay $3.8, whereas for Doximity, Inc., the investors are paying $21.6 for every $1 of sales.

Predictive Oncology Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$1.4M	↓ 0.01%
Net Income	$-19.4M	↑ 92.25%
Net Profit Margin	-1.4K%	↓ 659.2%

	FY20	Y/Y Change
Revenue	$1.3M	↓ 11.28%
Net Income	$-25.9M	↑ 33.49%
Net Profit Margin	-2.1K%	↓ 693.28%

	FY21	Y/Y Change
Revenue	$1.4M	↑ 13.45%
Net Income	$-19.7M	↓ 24.06%
Net Profit Margin	-1.4K%	↑ 683.34%

	FY22	Y/Y Change
Revenue	$1.5M	↑ 5.97%
Net Income	$-25.7M	↑ 30.93%
Net Profit Margin	-1.7K%	↓ 325.97%

	FY23	Y/Y Change
Revenue	$1.8M	↑ 18.24%
Net Income	$-14.0M	↓ 45.67%
Net Profit Margin	-785.58%	↑ 924.04%

	FY24	Y/Y Change
Revenue	$1.6M	↓ 8.78%
Net Income	$-12.2M	↓ 12.75%
Net Profit Margin	-751.39%	↑ 34.19%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$419.6K	↑ 25.26%
Net Income	$-4.2M	↑ 21.39%
Net Profit Margin	-1.0K%	↑ 31.99%

	Q2 FY24	Q/Q Change
Revenue	$278.7K	↓ 33.58%
Net Income	$-3.2M	↓ 24.59%
Net Profit Margin	-1.1K%	↓ 136.04%

	Q3 FY24	Q/Q Change
Revenue	$345.7K	↑ 24.03%
Net Income	$-3.1M	↓ 2.72%
Net Profit Margin	-895.23%	↑ 246.14%

	Q4 FY24	Q/Q Change
Revenue	$611.6K	↑ 76.92%
Net Income	$-2.2M	↓ 29.89%
Net Profit Margin	-354.75%	↑ 540.48%

	Q1 FY25	Q/Q Change
Revenue	$110.3K	↓ 81.96%
Net Income	$-2.4M	↑ 12.6%
Net Profit Margin	-2.2K%	↓ 1859.8%

	Q2 FY25	Q/Q Change
Revenue	$2.7K	↓ 97.57%
Net Income	$-2.1M	↓ 15.24%
Net Profit Margin	-77.2K%	↓ 74983.88%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$879.8K	↓ 11.66%

	FY20	Y/Y Change
Profit	$805.1K	↓ 8.49%

	FY21	Y/Y Change
Profit	$933.7K	↑ 15.97%

	FY22	Y/Y Change
Profit	$1.0M	↑ 7.14%

	FY23	Y/Y Change
Profit	$1.0M	↑ 1.81%

	FY24	Y/Y Change
Profit	$797.7K	↓ 21.68%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$69.7K	↓ 197.76%

	Q2 FY24	Q/Q Change
Profit	$125.8K	↑ 80.51%

	Q3 FY24	Q/Q Change
Profit	$148.8K	↑ 18.3%

	Q4 FY24	Q/Q Change
Profit	$321.0K	↑ 115.75%

	Q1 FY25	Q/Q Change
Profit	$65.2K	↓ 79.69%

	Q2 FY25	Q/Q Change
Profit	$-185.8K	↓ 385.0%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-8.7M	↑ 65.14%
Investing Cash Flow	$-599.1K	↓ 46.06%
Financing Cash Flow	$9.3M	↑ 60.84%

	FY20	Y/Y Change
Operating Cash Flow	$-12.3M	↑ 40.37%
Investing Cash Flow	$-167.5K	↓ 72.05%
Financing Cash Flow	$13.0M	↑ 38.97%

	FY21	Y/Y Change
Operating Cash Flow	$-12.2M	↓ 0.4%
Investing Cash Flow	$-10.6M	↑ 6234.52%
Financing Cash Flow	$50.3M	↑ 288.65%

	FY22	Y/Y Change
Operating Cash Flow	$-12.4M	↑ 1.33%
Investing Cash Flow	$-475.7K	↓ 95.52%
Financing Cash Flow	$6.7M	↓ 86.66%

	FY23	Y/Y Change
Operating Cash Flow	$-13.2M	↑ 6.62%
Investing Cash Flow	$-302.4K	↓ 36.44%
Financing Cash Flow	$148.9K	↓ 97.78%

	FY24	Y/Y Change
Operating Cash Flow	$-12.0M	↓ 9.35%
Investing Cash Flow	$22.5K	↓ 107.44%
Financing Cash Flow	$3.9M	↑ 2545.57%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-3.4M	↑ 10.82%
Investing Cash Flow	$-3.0K	↓ 141.56%
Financing Cash Flow	$-112.4K	↑ 0.94%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-3.2M	↓ 5.8%
Investing Cash Flow	$-6.5K	↑ 113.65%
Financing Cash Flow	$3.4M	↓ 3089.24%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-2.3M	↓ 29.16%
Investing Cash Flow	$32.0K	↓ 593.98%
Financing Cash Flow	$888.3K	↓ 73.56%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-3.0M	↑ 33.45%
Investing Cash Flow	$32.0K	↑ 0.0%
Financing Cash Flow	$-195.8K	↓ 122.04%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-756.3K	↓ 75.14%
Investing Cash Flow	$625.0K	↑ 1853.13%
Financing Cash Flow	$2.5M	↓ 1376.81%

Predictive Oncology Technicals Summary

Sell

Neutral

Buy

Predictive Oncology is currently in a neutral trading position according to technical analysis indicators.

Predictive Oncology Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Predictive Oncology Inc	10.61%	-30.74%	-8.71%	-89.18%	-95.96%
Tempus Ai	33.91%	48.79%	27.62%	88.27%	88.27%
Doximity, Inc.	15.66%	-0.73%	84.75%	104.73%	28.21%
Ge Healthcare Technologies Inc.	3.39%	-14.7%	-13.06%	21.9%	21.9%
Veeva Systems Inc.	-5.25%	22.99%	24.42%	35.1%	-4.6%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Predictive Oncology Inc	NA	NA	NA	0.0	-7.46	-0.88	NA	-0.17
Tempus Ai	34.26	34.26	NA	-0.73	-0.98	-0.12	NA	1.78
Doximity, Inc.	57.96	57.96	2.42	1.31	0.24	0.13	NA	5.47
Ge Healthcare Technologies Inc.	15.11	15.11	3.44	4.51	0.26	0.06	0.0	21.27
Veeva Systems Inc.	55.28	55.28	1.4	6.45	0.14	0.07	NA	40.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Predictive Oncology Inc	Buy	$10.0M	-95.96%	NA	0.0%
Tempus Ai	NA	$12.8B	88.27%	34.26	-20.98%
Doximity, Inc.	Hold	$12.7B	28.21%	57.96	39.88%
Ge Healthcare Technologies Inc.	Buy	$33.9B	21.9%	15.11	11.22%
Veeva Systems Inc.	Buy	$44.0B	-4.6%	55.28	27.29%

About Predictive Oncology Inc

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

Organization	Predictive Oncology
Employees	23
CEO	Mr. Raymond F. Vennare
Industry	Health Technology

Key Management of Predictive Oncology Inc

Name	Title
Mr. Raymond F. Vennare	CEO & Chairman
Mr. Joshua Blacher CPA, M.B.A.	Interim Chief Financial Officer
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.	Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.	Senior VP of Translational Medicine & Drug Discovery and Medical Director

Important FAQs about investing in POAI Stock from India :

What is Predictive Oncology share price today?

Predictive Oncology share price today is $0.87 as on August 30, 2025 at 1:29 am IST at the close of the market. Predictive Oncology share today touched a day high of $0.90 and a low of $0.87.

What is the 52 week high and 52 week low for Predictive Oncology share?

Predictive Oncology share touched a 52 week high of $3.06 and a 52 week low of $0.55. Predictive Oncology stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $0.87, lower by 71.57% versus the 52 week high.

How to invest in Predictive Oncology Stock (POAI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Predictive Oncology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Predictive Oncology Shares that will get you 1.7241 shares as per Predictive Oncology share price of $0.87 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Predictive Oncology Stock (POAI) from India?

Indian investors can start investing in Predictive Oncology (POAI) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Predictive Oncology stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Predictive Oncology share’s latest price of $0.87 as on August 30, 2025 at 1:29 am IST, you will get 11.4943 shares of Predictive Oncology. Learn more about fractional shares .

What are the returns that Predictive Oncology has given to Indian investors in the last 5 years?

Predictive Oncology stock has given -95.96% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?